158 related articles for article (PubMed ID: 7968260)
81. Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumours. Correlation with preoperative octreotide scintigraphy.
Papotti M; Croce S; Bellò M; Bongiovanni M; Allìa E; Schindler M; Bussolati G
Virchows Arch; 2001 Dec; 439(6):787-97. PubMed ID: 11787852
[TBL] [Abstract][Full Text] [Related]
82. Somatostatin regulates somatostatin receptor subtype mRNA expression in GH3 cells.
Bruno JF; Xu Y; Berelowitz M
Biochem Biophys Res Commun; 1994 Aug; 202(3):1738-43. PubMed ID: 7914724
[TBL] [Abstract][Full Text] [Related]
83. Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs.
Shimon I
Endocrine; 2003 Apr; 20(3):265-9. PubMed ID: 12721506
[TBL] [Abstract][Full Text] [Related]
84. Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium.
Ahmed SI; Thompson J; Coulson JM; Woll PJ
Am J Respir Cell Mol Biol; 2000 Apr; 22(4):422-31. PubMed ID: 10745023
[TBL] [Abstract][Full Text] [Related]
85. Reduced transcription of the RB2/p130 gene in human lung cancer.
Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
[TBL] [Abstract][Full Text] [Related]
86. Differential expression of somatostatin receptor subtypes in brain.
Breder CD; Yamada Y; Yasuda K; Seino S; Saper CB; Bell GI
J Neurosci; 1992 Oct; 12(10):3920-34. PubMed ID: 1403090
[TBL] [Abstract][Full Text] [Related]
87. Human cholangiocarcinomas express somatostatin receptors and respond to somatostatin with growth inhibition.
Tan CK; Podila PV; Taylor JE; Nagorney DM; Wiseman GA; Gores GJ; LaRusso NF
Gastroenterology; 1995 Jun; 108(6):1908-16. PubMed ID: 7768398
[TBL] [Abstract][Full Text] [Related]
88. 111In-labelled octreotide binding by the somatostatin receptor subtype 2 in neuroendocrine tumours.
Hashemi SH; Benjegård SA; Ahlman H; Wängberg B; Forssell-Aronsson E; Billig H; Nilsson O
Br J Surg; 2003 May; 90(5):549-54. PubMed ID: 12734860
[TBL] [Abstract][Full Text] [Related]
89. Expression of the SST receptor 2 in uveal melanoma is not a prognostic marker.
Kouch-el Filali M; Kilic E; Melis M; de Klein A; de Jong M; Luyten GP
Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1585-92. PubMed ID: 18682975
[TBL] [Abstract][Full Text] [Related]
90. Messenger RNA expression of somatostatin receptor subtypes in human and rat gastric mucosae.
Le Romancer M; Cherifi Y; Levasseur S; Laigneau JP; Peranzi G; Jais P; Lewin MJ; Reyl-Desmars F
Life Sci; 1996; 58(13):1091-8. PubMed ID: 8622562
[TBL] [Abstract][Full Text] [Related]
91. Molecular and biological features of two new human squamous and adenocarcinoma of the lung cell lines.
Gasperi-Campani A; Roncuzzi L; Ricotti L; Lenzi L; Gruppioni R; Sensi A; Zini N; Zoli W; Amadori D
Cancer Genet Cytogenet; 1998 Nov; 107(1):11-20. PubMed ID: 9809028
[TBL] [Abstract][Full Text] [Related]
92. Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung Cancer.
Whalen KA; White BH; Quinn JM; Kriksciukaite K; Alargova R; Au Yeung TP; Bazinet P; Brockman A; DuPont MM; Oller H; Gifford J; Lemelin CA; Lim Soo P; Perino S; Moreau B; Sharma G; Shinde R; Sweryda-Krawiec B; Bilodeau MT; Wooster R
Mol Cancer Ther; 2019 Nov; 18(11):1926-1936. PubMed ID: 31649014
[TBL] [Abstract][Full Text] [Related]
93. GIPR expression in gastric and duodenal neuroendocrine tumors.
Sherman SK; Maxwell JE; Carr JC; Wang D; O'Dorisio MS; O'Dorisio TM; Howe JR
J Surg Res; 2014 Aug; 190(2):587-93. PubMed ID: 24565507
[TBL] [Abstract][Full Text] [Related]
94. Somatostatin and the lung.
O'Byrne KJ; Carney DN
Lung Cancer; 1993 Dec; 10(3-4):151-72. PubMed ID: 7915618
[TBL] [Abstract][Full Text] [Related]
95. Expression of cytokeratin 19 mRNA in human lung cancer cell lines.
Ueda Y; Fujita J; Bandoh S; Hojo S; Yamaji Y; Ohtsuki Y; Dobashi N; Takahara J
Int J Cancer; 1999 Jun; 81(6):939-43. PubMed ID: 10362142
[TBL] [Abstract][Full Text] [Related]
96. Characterization of somatostatin receptor expression in human pancreatic cancer using real-time RT-PCR.
Li M; Li W; Kim HJ; Yao Q; Chen C; Fisher WE
J Surg Res; 2004 Jun; 119(2):130-7. PubMed ID: 15145694
[TBL] [Abstract][Full Text] [Related]
97. Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS 201-995 for the SSTR2 somatostatin receptor.
Kaupmann K; Bruns C; Raulf F; Weber HP; Mattes H; Lübbert H
EMBO J; 1995 Feb; 14(4):727-35. PubMed ID: 7882976
[TBL] [Abstract][Full Text] [Related]
98. Production of platelet-derived growth factor by human lung cancer.
Bravo M; Vàsquez R; Rubio H; Salazar M; Pardo A; Selman M
Respir Med; 1991 Nov; 85(6):479-85. PubMed ID: 1663641
[TBL] [Abstract][Full Text] [Related]
99. The release of chromogranin A and B like activity from human lung cancer cell lines. A potential marker for a subset of small cell lung cancer.
Bergh J; Arnberg H; Eriksson B; Lundqvist G
Acta Oncol; 1989; 28(5):651-4. PubMed ID: 2556168
[TBL] [Abstract][Full Text] [Related]
100. Growth inhibitory effects of somatostatin on human leukemia cell lines mediated by somatostatin receptor subtype 1.
Ishihara S; Hassan S; Kinoshita Y; Moriyama N; Fukuda R; Maekawa T; Okada A; Chiba T
Peptides; 1999; 20(3):313-8. PubMed ID: 10447088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
